Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum
- 1 June 1993
- journal article
- Published by Elsevier in Neuroscience
- Vol. 54 (3) , 669-680
- https://doi.org/10.1016/0306-4522(93)90238-b
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatumDevelopmental Brain Research, 1991
- Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the ratMolecular Brain Research, 1991
- Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamineNeuropharmacology, 1991
- Rapid reversal of denervation supersenssitivity of dopamine D1 receptors by 1-dopa or a novel dopamamine D1 receptor agonist, A68930European Journal of Pharmacology, 1991
- Differential ontogenetic expression and regulation of proenkephalin and preprosomatostatin mRNAs in rat caudate-putamen as studied by in situ hybridization histochemistryDevelopmental Brain Research, 1991
- Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous systemCellular and Molecular Neurobiology, 1989
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- Interaction of dopamine receptor ligands with subtypes of the opiate receptorEuropean Journal of Pharmacology, 1984
- Computer-assisted video analysis of [3H]spiroperidol binding autoradiographsJournal of Neuroscience Methods, 1984
- Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleusNature, 1981